SCHEMBL4903777

SCHEMBL4903777

CCN(c1nc(-c2ccc3ccccc3c2)sc1C)S(=O)(=O)c1cc(C)c(C)c(C(=O)O)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.39
TRPM8 Q7Z2W7 6/20 0.38
ALDH1A1 P00352 1/20 0.37
HPGD P15428 1/20 0.37
ALOX15 P16050 1/20 0.37
HSD17B10 Q99714 1/20 0.37
MCL1 Q07820 3/20 0.36
BCL2L1 Q07817 2/20 0.36
ESR1 P03372 2/20 0.36
PTGES O14684 2/20 0.36
ALOX5 P09917 2/20 0.36
KMT2A Q03164 2/20 0.34
MEN1 O00255 1/20 0.34
PTGER4 P35408 1/20 0.34
ACMSD Q8TDX5 1/20 0.34
MMP1 P03956 1/20 0.34
MMP9 P14780 1/20 0.34
MMP13 P45452 1/20 0.34
ADAM17 P78536 1/20 0.34
NSD2 O96028 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4903806 0.92 LMNA (0.42) LMNATRPM8ALDH1A1HPGDALOX15
SCHEMBL4906570 0.90 SLC6A3 (0.39) LMNATRPM8ALDH1A1HPGDHSD17B10
SCHEMBL4908264 0.90 LMNA (0.44) LMNATRPM8ALDH1A1HPGDALOX15
SCHEMBL4903647 0.89 ALDH1A1 (0.39) LMNATRPM8ALDH1A1HPGDALOX15
SCHEMBL4904359 0.87 KDM4E (0.40) LMNATRPM8ALDH1A1HPGDALOX15
SCHEMBL4906619 0.87 LMNA (0.40) LMNATRPM8ALDH1A1HPGDALOX15
SCHEMBL4908424 0.86 LMNA (0.42) LMNAALDH1A1HPGDALOX15HSD17B10
SCHEMBL4907500 0.85 TRPM8 (0.39) LMNATRPM8ALDH1A1HPGDALOX15
SCHEMBL4901379 0.85 KDM4E (0.41) LMNATRPM8ALDH1A1KMT2AMEN1
SCHEMBL4906218 0.84 TRPM8 (0.45) TRPM8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD LMNA 319/4885TRPM8 4317/4885ALDH1A1 2956/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD LMNA 319/4885TRPM8 4317/4885ALDH1A1 2956/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.